Clinical trial: A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Patients With Primary Progressive Multiple Sclerosis.

https://clinicaltrials.gov/study/NCT04544449?utm_source=fediverse&utm_medium=mastodon&utm_content=trial_16690

#ClinicalTrials #MultipleSclerosis #MSchat #Neurology